Answers are grounded in this paper and cite their sources.
Allergen immunotherapy (AIT) is the only “disease-modifying therapy,” i.e., available in the management of allergic disorders. The success of AIT depends on appropriate patient selection, allergen selection, as well as the quality of allergen extracts and compliance. Challenges that we face with immunotherapy practice in India are different from the Western world due to various causes discussed in this chapter.
No takes yet. Share an insight, caveat, or question.
Pandit et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: